Immunomedics (IMMU) $33 | Raising Price Potential to $60. American BriVision (ABVC) $3.00 |...
We Are Raising the Price Potential of Immunomedics (IMMU) to $60, Highest on the Street, and Initiating Coverage on Another $3.00 Medical Start-Up American...
Corona Craziness Continues. Organicell (BPSR) Gains 10-fold or 1000%, in Six Weeks.
Too bad we don't trade for a living! We don't even use real-time quotes, LOL. $0.02 to $0.27, from Easter - what HOOT-N-HOLLER.
LIVE CHART
RELATED:...
MRSA: Can Kill Within 24 Hours. Here Are Some Basics.
RESIST THE RESISTANCE: A PRIMER ON ANTIBIOTICS & ANTIBIOTIC RESISTANCE (2013)
I was going to write this week about how DEET works, as a follow-up...
MRSA: Methicillin (antibiotic) Resistant Staphylococcus Aureus.
Antibiotic-resistant staph bacteria can lie hidden on your skin for years!
Staphylococcus aureus (SA) is a bacterium found in the nose or on the skin...
Organicell (BPSR) a Triple Since Easter.
Slowly she turns, step-by-step. $20 million gain in market value. Spurred by FDA Emergency IND's.
RELATED: Adding Organicell (BPSR) $0.02 to the Watch List.
FDA Approves...
Deficiency of Glutathione as the Most Likely Cause of Serious Manifestations and Death in...
American Chemical Society
May 2020.
Higher rates of serious illness and death from coronavirus SARS-CoV-2 (COVID-19) infection among older people and those who have comorbidities...
How CoronaVirus Accelerated the Rise of Telemedicine (CNBC). Telehealth.
16 minute video on how hospitals and primary care practices are using it and what it could mean for the future of health care.
The Covid-19...
After FDA authorizes at-home saliva test for Covid-19, startups begin selling test kits.
MedCityNews
The FDA gave an emergency use authorization for the first saliva-based Covid-19 test developed by RUCDR Infinite Biologics. Now, startups are once again trying...
Biotech Stock Review Adds One Medical (ONEM) $28.50 to Watchlist.
It Ain't Cheap at $3.5 Billion.It's Near Doubled Since March 20th.But Look at the Growth.Look at the Cash.Don't Look at the Bottom Line.And it's...















